Korea Investment Corp Alkermes Plc. Transaction History

Korea Investment Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$13.06 - $21.24 $2.38 Million - $3.88 Million	-182,500 Closed	0 $0
Q4 2019 Feb 11, 2020	SELL	$17.29 - $21.74 $10.7 Million - $13.4 Million	-617,627 Reduced 77.19%	182,500 $3.72 Million
Q3 2019 Nov 12, 2019	SELL	$19.51 - $24.28 $2.57 Million - $3.2 Million	-131,654 Reduced 14.13%	800,127 $15.6 Million
Q2 2019 Aug 12, 2019	BUY	$21.47 - $37.33 $8.24 Million - $14.3 Million	383,700 Added 70.01%	931,781 $21 Million
Q1 2019 May 15, 2019	BUY	$28.4 - $36.49 $1.61 Million - $2.07 Million	56,600 Added 11.52%	548,081 $20 Million
Q4 2018 Feb 13, 2019	BUY	$27.94 - $44.61 $7.4 Million - $11.8 Million	264,900 Added 116.91%	491,481 $14.5 Million
Q3 2018 Nov 13, 2018	BUY	$38.6 - $46.12 $5.8 Million - $6.93 Million	150,200 Added 196.65%	226,581 $9.62 Million
Q2 2018 Aug 13, 2018	BUY	$40.56 - $51.36 $2.54 Million - $3.22 Million	62,700 Added 458.3%	76,381 $0
Q1 2018 May 09, 2018	BUY	$53.61 - $67.26 $733,438 - $920,184	13,681 New	13,681 $793,000

362

181M

175K

96.6K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.9B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of Korea Investment Corp, based on Form 13F filings with the SEC.

Stay updated on Korea Investment Corp with notifications on news.